A Quality Improvement Approach to Rheumatoid Arthritis Management With Biologic Disease-Modifying Antirheumatic Drugs: Assessing Variability in a Treatment Pathway

January 1, 2017

A quality improvement project to improve rheumatoid arthritis management in clinical practice was supported by CRICO funds. The aim of the research was to understand the variability in prescribing practices of rheumatologists and reducing this variability if and when appropriate.

This initiative, conducted at the Arthritis Center at Brigham and Women’s Hospital, had three distinct but related steps:

Development of an internally endorsed treatment pathway.
Detailed retrospective Chart reviews.
Improved documentation of functional status and disease activity measures.

Citation for the Full-text Article

Dave AJ, Tory HO, Awosogba JA, Coblyn JS, Bermas B, Solomon DH, Desai SP. A quality improvement approach to rheumatoid Arthritis management with biologic disease-modifying antirheumatic drugs: assessing variability in a treatment pathway. J Clin Rheumatol. 2017 Jan;23(1):66-69. doi: 10.1097/RHU.0000000000000474.

Research resulting from CRICO grants and projects

CRICO home

Recent Coverage

Development of a Taxonomy for Characterising Medical Oncology-related Patient Safety and Quality Incidents: A Novel Approach

Trial and Error: Learning From Malpractice Claims in Childhood Surgery

Frequency and Nature of Communication and Handoff Failures in Medical Malpractice Claims

A Quality Improvement Approach to Rheumatoid Arthritis Management With Biologic Disease-Modifying Antirheumatic Drugs: Assessing Variability in a Treatment Pathway